July 7, 2025

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

NRG Oncology Summer Meeting Registration is OPEN

More information can be found on our

Summer Meeting

webpage. 

NRG SUMMER MEETING

Register Today!

Join us in Washington DC for the NRG2025 Summer Meeting. The meeting will be held in-person at the Marriott Marquis, July 24-26, 2025, with select virtual sessions being held July 16-25, 2025. ($50 late registration fee now in effect)

More information | Agenda | Register

 

Real ID Reminder - Travel Requirements

As of May 7, 2025, a REAL ID or another acceptable form of identification, like a passport, is required to board domestic flights. Please visit the DHS website for more information on this travel requirement.

NRG Summer 2025 Symposium - Antibody Drug Conjugates: Selection, Sequencing and Future Strategies in Solid Tumors

Join us on in Washington, DC on Thursday, July 24, 2025 from 8am-12pm ET. The session will also be available virtually. This symposium offers a valuable opportunity to explore the expanding role of ADCs in the treatment of ovarian, cervical, endometrial, breast, lung, genitourinary and gastrointestinal cancers, highlighting their impact on clinical practice and patient outcomes. Program Chair - Kathleen Moore, MD and Co-Chair - Paolo Tarantino, MD

More information | Register

NRG Advanced Practice Provider (APP) Symposium

Calling all APPs! We are pleased to announce our NRG Oncology Advanced Practice Providers (APP) Symposium to be held during the NRG2025 Summer Meeting in Washington, DC on Friday, July 25, 2025, 8:15-9:45am ET. The session will also be available virtually. The goals for the session will be to identify the different roles that APPs can serve in NCI-sponsored research and elevate their involvement in clinical research at practice sites. The session chairs are Deb Bruner, Kathleen Castro, Christa Braun-Inglis, and Melyssa Foust.

More information | Register

NRG Oncology Protocol Support Committee (PSC) – Educational Sessions

Please be sure to sign up to attend the PSC Sessions being held during the NRG Oncology Summer Meeting in Washington, DC. The PSC will host a Continuing Education session, a Lunch and Learn and Roundtable presentations on Thursday, July 24; and a Protocol Spotlight Session (NRG-CC015 / NRG-GY036 / NRG-BR009) on Friday, July 25. Please refer to the posted flyers or agendas (login required) for more details about the PSC programing offered at #NRG2025. The PSC programming at #NRG2025 has been approved by the Virginia Nurses Association to award contact hours. The Virginia Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.



Communications & Digital Engagement Workshop

The NRG Oncology Communications Committee is pleased to announce our Communications & Digital Engagement (CDE) Workshop as part of #NRG2025. The workshop, being held as a virtual session, is scheduled for Monday, July 21, 2025, 1-2pm ET. Drs. Kristin Higgins and Miriam Knoll, members of the NRG Oncology Communications Committee, are the session chairs. The speakers include Dr. Patricia Ganz who will discuss the recently activated, NRG-CC015/HEAL-ABC study; Ryan Strandlund, Associate Director for ASCO’s Grassroots Advocacy for Cancer program; and Sara Rothchild, Executive Director for The Life Raft Group, which focuses on advocacy for people living with Gastrointestinal Stromal Tumor (GIST), and other rare diseases.

Flyer | Register

CLOSURE

GYNECOLOGIC

NRG-GY028: Permanently closed to accrual on July 1, 2025; version date: January 3, 2025 (posted on CTSU)

AMENDMENT

GYNECOLOGIC

NRG-CC010: Amendment 2; version date: April 29, 2025 (posted on CTSU)

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANK

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. BRAIN

NRG-BN011: Reminder! Please ensure you are using the most recent version of the Central Pathology Form (P4). The correct version date is November 4, 2024 and is posted to CTSU.

4. BREAST

NRG-BR008/HERO:

Reminder that this trial is open and actively enrolling patients. Helpful materials pertaining to BR008 can be found on the NRG Oncology website under Clinical Trials/NRG-BR008/Documents & Materials or on the CTSU website.

5. CANCER CARE DELIVERY RESEARCH

NRG-CC012CD: Spanish Translated Consent form, dated May 29, 2025, and CIRB approval posted to CTSU.

6. GYNECOLOGIC

NRG-GY026: Reminder! Now accruing patients of all stages and all histologic subtypes of endometrial cancer.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

7. HEAD & NECK

NRG-HN008: Reminder! Please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

 

8. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-BN014, NRG-BR009, NRG-CC003, NRG-CC005, NRG-CC011, NRG-CC013, NRG-CC014, NRG-HN001, NRG-HN002, and NRG-HN014. Space is limited so register now and reserve your seat. The next webinar training is scheduled for July 9, 2025.

RFA for Vice Chair, NRG Patient Advocate Committee

Applications DUE July 8, 2025 - Read more and how to apply

RFA for Vice Chair, NRG VA-MTF Subcommittee

Applications DUE July 14, 2024 - Read more and how to apply

Membership Reminders: Please take a moment to review and update your site person rosters! 

NRG Oncology Members are required to designate individuals to fill the NRG Oncology Primary Roles. Primary Roles are:

• Check Addressee
• Contact PI
• LAPS PI
• Lead RA
• Co-Lead RA (optional)
• Local Lead RA
• Principal Investigator (A maximum of 3 and the contact PI is counted as 1)

These roles are used to communicate with respect to NRG Oncology studies, initiate and support staff access requests, and other important information. In order for a person to be assigned a Primary Role, he/she must have an active CTEP ID and be listed on the site's NRG Oncology Roster for the specific institution. A completed NRG Primary Role Change Form (located on NRG Oncology website, under Membership) must be submitted to roster@nrgoncology.org for any Primary Role changes.

The Roster Update Management System (RUMS) allows authorized people at clinical sites to manage roster data for secondary roles using a web-based application. Authorized persons can use RUMS to manage person secondary roles, to request the addition or withdrawal of persons to their associated clinical sites, and to request the addition or withdrawal of child sites from their local network. NCORP authorized users should request rostering of NCORP sites, investigators, and research associates via NCORP-SYS. A person must be rostered before any roles may be requested in RUMS. 

Required secondary roles are Local PI, Contract Contact, Fiscal Contact. A reminder that each NRG site can only have one (1) Local Lead RA and (1) Local PI at any time.

Please take a moment and review your roster using RUMS or NCORP-SYS as applicable to ensure all your network personnel are up to date. Contact roster@nrgoncology.org for assistance.

NRG Member Information Form

We are excited to introduce the NRG Member Information Data Collection Initiative that will allow us to create a comprehensive member database, enabling us to better understand and serve our members. Your information will be kept secure and confidential, ensuring that your privacy is always protected. All members are encouraged to complete the form or indicate that they wish to opt out of this data collection initiative. 

Scan the QR code below or click this link to access the form. 

Questions? Read more here

NRG Oncology is pleased to report the scientific articles that appeared during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

PUBLISHED ARTICLES

Lee JM, Miller A, Rose PG, AlHilli M, Washington C, John VS, Shah CA, Matsuo K, Siedel J, Miller DS, Hopp EE, O'Shea A, Chan JK, Bradford LS, Morse CB, Nagel CI, Rodabaugh KJ, Kohn EC, Moore KN, Liu JF. Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial. Clin Cancer Res. 2025 Jun 13;31(12):2370-2378. doi: 10.1158/1078-0432.CCR-24-3877. PMID: 40192715; PMCID: PMC12165816. Read more.

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS:

AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Sep 18-21, 2025; Baltimore, MD

Canadian Association of Radiation Oncology (CARO); Sep 10-13, 2025; Calgary, AB

International Society for Quality-of-Life Research (ISOQOL); Oct 22-25, 2025; Milwaukee, WI

Radiological Society of North America (RSNA); Nov 30-Dec 4, 2025; Chicago, IL

Society for Immunotherapy of Cancer (SITC); Nov 5-9, 2025; National Harbor, MD

UPCOMING ABSTRACT SUBMISSION DEADLINES:

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; Oct 22-26, 2025; Boston, MA; Due to publications committee Jul 7, 2025; Submission deadline Jul 21, 2025, 1:00 pm ET; LBA and Clinical Trials Sep 10, 2025, 1:00 pm ET

American Society for Radiation Oncology (ASTRO); Sep 28-Oct 1, 2025; San Francisco, CA; LBA Jul 10, 2025, 11:59 pm PT

European Society for Medical Oncology (ESMO); Oct 17-21, 2025; Berlin, Germany; LBA Sep 9, 2025, 21:00 CET (placeholder required)

European Society of Gynaecological Oncology (ESGO); Feb 26-Mar 1, 2026; Copenhagen, Denmark; Due to publications Oct 17, 2025; Submission deadline Oct 31, 2026, 23:59 CET; LBA Jan 15, 2026

International Gynecologic Cancer Society (IGCS); Nov 5-7, 2025; Cape Town, South Africa; LBA Sep 29, 2025 (placeholder required)

San Antonio Breast Cancer Symposium (SABCS); Dec 9-12, 2025; San Antonio, TX; Submission deadline Jul 9, 2025, 6:00 pm CT; LBA Sep 30, 2025, 11:59 pm CT

Society for Neuro-Oncology (SNO); Nov 19-23, 2025; Honolulu, HI; LBA Sep 2, 2025, 5:00 pm ET

Society of Urologic Oncology (SUO); Dec 2-5, 2025; Dallas, TX; Due to publications committee Jul 22, 2025; Submission deadline Aug 5, 2025